221 related articles for article (PubMed ID: 15600380)
1. Metabolic syndrome: epidemiology and consequences.
Sacks FM
J Clin Psychiatry; 2004; 65 Suppl 18():3-12. PubMed ID: 15600380
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and mental illness.
Newcomer JW
Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
[TBL] [Abstract][Full Text] [Related]
3. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
4. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
Tirupati S; Chua LE
Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric diagnosis in children and adolescents with obesity-related health conditions.
Janicke DM; Harman JS; Kelleher KJ; Zhang J
J Dev Behav Pediatr; 2008 Aug; 29(4):276-84. PubMed ID: 18562982
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing DA
J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
[TBL] [Abstract][Full Text] [Related]
7. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.
Megna JL; Schwartz TL; Siddiqui UA; Herrera Rojas M
Ann Clin Psychiatry; 2011 May; 23(2):131-40. PubMed ID: 21547274
[TBL] [Abstract][Full Text] [Related]
8. Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.
Newcomer JW
J Clin Psychiatry; 2009; 70 Suppl 3():30-6. PubMed ID: 19570499
[TBL] [Abstract][Full Text] [Related]
9. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis as the marker of underlying systemic disease.
Kourosh AS; Miner A; Menter A
Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
12. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
Ballantyne CM
Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
14. Side effects as influencers of treatment outcome.
Sharif Z
J Clin Psychiatry; 2008; 69 Suppl 3():38-43. PubMed ID: 18533761
[TBL] [Abstract][Full Text] [Related]
15. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome and schizophrenia.
Meyer JM; Stahl SM
Acta Psychiatr Scand; 2009 Jan; 119(1):4-14. PubMed ID: 19133915
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, morbidity, and treatment of overweight and obesity.
Aronne LJ
J Clin Psychiatry; 2001; 62 Suppl 23():13-22. PubMed ID: 11603881
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome: practical guide to origins and treatment: Part I.
Wilson PW; Grundy SM
Circulation; 2003 Sep; 108(12):1422-4. PubMed ID: 14504251
[No Abstract] [Full Text] [Related]
19. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
Kozumplik O; Uzun S; Jakovljević M
Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
[TBL] [Abstract][Full Text] [Related]
20. Mental disorders and metabolic syndrome: a fatamorgana or warning reality?
Jakovljević M; Crncević Z; Ljubicić D; Babić D; Topić R; Sarić M
Psychiatr Danub; 2007 Jun; 19(1-2):76-86. PubMed ID: 17603420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]